Advanced Prostate Cancer VL

Patient-Reported Outcomes (PROs): Personalizing Care in Clinical Practice - Alicia Morgans

Details
Patient-Reported Outcomes (PRO): Personalizing Care in Clinical Practice Biography: Alicia Morgans, MD, MPH Related Content: Tools for predicting patient-reported outcomes (PROs): Optimizing Use in Clinical Practice

Standardization for Prostate Cancer Radical Prostatectomy Reporting for Locally Advanced Disease - Mark A Rubin

Details
Mark A. Rubin, MD is a recognized world leader in the area of prostate cancer genomics and pathology and openned his presentation on the recently published " Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual". He went on to discuss the significant changes included in this publication and its move towards consensus. (Presentation in 8:57)...

Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

Details
In this slide presentation, Stephen Williams details using biomarkers to determine when to biopsy and when to repeat a prostate biopsy specifically: PSA, PHI, 4K, PCA3 and Confirm MDx. He overviews the patient journey pre and post biopsy and the process of determining which patients need a rebiopsy. Biography: Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track, Robert Earl Cone P...

Active Surveillance: Protecting Patients From Harm- Laurence Klotz

Details
Protecting Patients From Harm - Active Surveillance Biographies: Thomas E Keane Laurence Klotz, MD Related Content: Active Surveillance in PCa+ Active surveillance in prostate cancer: a critical review

IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer- Lorelei Mucci

Details
IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer Biographies: Alicia Morgans, MD, MPH Lorelei Mucci, ScD, MPH Also check out Lorelei Mucci & Philip Kantoff on Outcomes Research and the IRONMAN Project Related Content: Watch: IRONMAN - A Better Understanding of the Variation in Care and Treatment - Daniel George Watch: Lorelei Mucci and Philip Kantoff on O...

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer - Stacy Loeb

Details
(Length of discussion - 17 minutes) Medical or surgical castration are currently the mainstay of therapy for advanced prostate cancer. However, there is controversy regarding the association between testosterone replacement therapy (TRT) and advanced prostate cancer risk. Studies on this have been done in the past and the data was combined in a meta-analysis concluding that there is no increased r...

Non-Controversial Topics in Prostate Cancer - William Oh

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Debate Position: Optimal Rx for Oligometastatic Disease is Multimodality - Charles Ryan

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Arbiter: Oligometastatic Disease - Robert Bristow

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe